Reduction of Transfusion Burden (TB), Hemoglobin Increase, and Dose Titration in the COMMANDS Study of Luspatercept Versus Epoetin Alfa (EA) in Erythropoietin-Stimulating Agent (ESA)-Naive Patients With Transfusion-Dependent (TD) Lower-Risk Myelodysplastic Syndromes (LR-MDS)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
MDS,myelodysplastic neoplasms,erythroid response,clinical benefit,RBC transfusion independence,ESA-naive,phase III
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要